1. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 131:861–872. PMID:
18035408.
2. Kamao H, Mandai M, Okamoto S, et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports 2014 2:205–218. PMID:
24527394.
3. Doi D, Samata B, Katsukawa M, et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports 2014 2:337–350. PMID:
24672756.
4. Kanematsu D, Shofuda T, Yamamoto A, et al. Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. Differentiation 2011 82:77–88. PMID:
21684674.
5. Okita K, Matsumura Y, Sato Y, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011 8:409–412. PMID:
21460823.
7. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002 100:3175–3182. PMID:
12384415.
8. Wang J, Gallagher D, DeVito LM, et al. Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell Stem Cell 2012 11:23–35. PMID:
22770240.
9. Kanemura Y, Mori H, Kobayashi S, et al. Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J Neurosci Res 2002 69:869–879. PMID:
12205680.
10. Nakamura Y, Yamamoto M, Oda E, et al. Expression of tubulin beta II in neural stem/progenitor cells and radial fibers during human fetal brain development. Lab Invest 2003 83:479–489. PMID:
12695551.
11. Shofuda T, Fukusumi H, Kanematsu D, et al. A method for efficiently generating neurospheres from human-induced pluripotent stem cells using microsphere arrays. Neuroreport 2013 24:84–90. PMID:
23238165.
12. Fukusumi H, Shofuda T, Kanematsu D, et al. Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells. PLoS One 2013 8:e55226. PMID:
23383118.
13. Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 2010 107:12704–12709. PMID:
20615974.
14. Yasuda A, Tsuji O, Shibata S, et al. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord. Stem Cells 2011 29:1983–1994. PMID:
22028197.
15. Nori S, Okada Y, Yasuda A, et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A 2011 108:16825–16830. PMID:
21949375.
16. Fujimoto Y, Abematsu M, Falk A, et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012 30:1163–1173. PMID:
22419556.
17. Kobayashi Y, Okada Y, Itakura G, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 2012 7:e52787. PMID:
23300777.
18. Stiefel D, Meuli M. Scanning electron microscopy of fetal murine myelomeningocele reveals growth and development of the spinal cord in early gestation and neural tissue destruction around birth. J Pediatr Surg 2007 42:1561–1565. PMID:
17848249.
19. Lee DH, Park S, Kim EY, et al. Enhancement of reclosure capacity by the intra-amniotic injection of human embryonic stem cells in surgically induced spinal open neural tube defects in chick embryos. Neurosci Lett 2004 364:98–100. PMID:
15196686.
20. Saadai P, Wang A, Nout YS, et al. Human induced pluripotent stem cell-derived neural crest stem cells integrate into the injured spinal cord in the fetal lamb model of myelomeningocele. J Pediatr Surg 2013 48:158–163. PMID:
23331809.
21. Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013 12:407–412. PMID:
23352605.
22. Araki R, Uda M, Hoki Y, et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 2013 494:100–104. PMID:
23302801.
23. Morizane A, Doi D, Kikuchi T, et al. Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Reports 2013 1:283–292. PMID:
24319664.
24. Fauza DO, Jennings RW, Teng YD, Snyder EY. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida. Surgery 2008 144:367–373. PMID:
18707035.
25. Turner CG, Klein JD, Wang J, et al. The amniotic fluid as a source of neural stem cells in the setting of experimental neural tube defects. Stem Cells Dev 2013 22:548–553. PMID:
22957979.
26. Li H, Gao F, Ma L, et al. Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta. J Cell Mol Med 2012 16:1606–1617. PMID:
22004004.
27. Sharma AK, Bury MI, Fuller NJ, et al. Cotransplantation with specific populations of spina bifida bone marrow stem/progenitor cells enhances urinary bladder regeneration. Proc Natl Acad Sci U S A 2013 110:4003–4008. PMID:
23431178.
28. Okano H, Nakamura M, Yoshida K, et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 2013 112:523–533. PMID:
23371901.
29. Okano H, Yamanaka S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain 2014 7:22PMID:
24685317.